Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 11 | Rosett MaxChief Financial Officer | Option exercise · 10b5-1 plan | M | — 31.8K sh | Apr 3, 2026 |
| 11 | Mazzara PhilipGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $109K 1,000 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 11 | Allison JonathanChief Administrative Officer | Option exercise · 10b5-1 plan | M | — 6,442 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 11 | Mazzara PhilipGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $213K 1,985 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 11 | Mazzara PhilipGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $55K 500 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 11 | Rosett MaxChief Financial Officer | Option exercise · 10b5-1 plan | M | $33K 31.8K sh | Apr 3, 2026 traded Apr 2, 2026 |
| 11 | Raghavan VaidyanathanChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $65K 1,541 sh | Apr 3, 2026 traded Apr 2, 2026 |
| 10 | Rosett MaxChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $30K 1,344 sh | Apr 3, 2026 traded Apr 2, 2026 |
| 10 | McGrane AshleyGeneral Counsel and Corp Sec | Open-market sale · 10b5-1 plan | SELL | $41K 6,959 sh | Apr 3, 2026 traded Apr 2, 2026 |
| 9 | Hartley DylanChief Scientific Officer | Grant or award | A | — 110.0K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Fernandez Pagan AnnetteChief Operating Officer | Grant or award | A | — 30.0K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Eslicker Rachel R.SVP & GENERAL COUNSEL | Tax withholding | F | $44K 31 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | O'Brien Michael GrahamCFO | Option exercise | M | — 765 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Salgar MauricioDirector | Grant or award | A | — 7,500 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Powell RikkiChief Financial Officer | Grant or award | A | — 60.8K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Xu RanDirector, Chief Executive Officer | Grant or award | A | — 80.0K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Canales Saldana GloriaDirector | Grant or award | A | — 7,500 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Klimenko PaulinaCHIEF GROWTH OFFICER | Option exercise | M | — 6,484 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Canales Saldana GloriaDirector | Grant or award | A | — 7,500 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Wang FengyingPresident | Option exercise | M | — 600.0K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | King Melissa AnnSVP Product and Technology | Tax withholding | F | $35K 321 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Rinsky JasonEVP Chief Tax and Treasury | Option exercise | M | — 3,795 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | McGowan Brian JeffreySee Remarks | Tax withholding | F | $22K 676 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Tansil Scott J.Chief Bus. & Operations Off. | Tax withholding | F | $26K 485 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Allison JonathanChief Administrative Officer | Tax withholding · 10b5-1 plan | F | $350K 8,081 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | McKemey AdrianPresident, Drug Dev. Solutions | Option exercise | M | — 10.8K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Beri SanjayDirector, CEO and Chairman | Option exercise | M | — 564.3K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Salgar MauricioDirector | Grant or award | A | — 7,500 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Matsler NatalieSee Remarks. | Grant or award | A | — 25.6K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Xu RanDirector, Chief Executive Officer | Option exercise | M | — 10.0K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | O'Hara David MarkDirector | Grant or award | A | $19K 3,267 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Gold KellyChief Financial Officer | Grant or award | A | — 215.0K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | McGowan Brian JeffreySee Remarks | Grant or award | A | — 28.8K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Wright Andrew William BanasickSVP, GC & Secretary | Tax withholding | F | $7,224 3,863 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Minor BradleyChief Marketing Officer | Option exercise | M | — 3,983 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Hickman MarkChief Human Resources Officer | Tax withholding | F | $21K 401 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Stein James D.Director | Grant or award | A | — 372.9K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Wilson Robert AllenSVP, General Counsel & CCO | Grant or award | A | — 24.1K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Davis Gregory DHead of Research & Technology | Grant or award | A | — 225.0K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Tardiff DanielChief Scientific Officer | Grant or award | A | — 170.0K sh | Apr 3, 2026 traded Apr 1, 2026 |